542 related articles for article (PubMed ID: 18804269)
1. Immunoglobulin therapy: methods of delivery.
Ballow M
J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
[No Abstract] [Full Text] [Related]
2. IgG replacement therapy, no size fits all.
Bonilla FA
Clin Immunol; 2011 May; 139(2):107-9. PubMed ID: 21420364
[No Abstract] [Full Text] [Related]
3. New choices for treatment with subcutaneous immunoglobulins.
Pleguezuelo DE; Sánchez-Ramón S
Med Clin (Barc); 2017 Jan; 148(2):86-90. PubMed ID: 27919413
[No Abstract] [Full Text] [Related]
4. [Immunoglobulins and immune deficiency: methods of administration].
Suarez F
Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260
[No Abstract] [Full Text] [Related]
5. [Immunoglobulin therapy of primary humoral immunologic deficiencies].
Bordigoni P
Rev Prat; 2007 Oct; 57(15):1691-8. PubMed ID: 18080428
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomics of immunoglobulins in primary immunodeficiency.
Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):375-86. PubMed ID: 19670998
[TBL] [Abstract][Full Text] [Related]
7. [Patient handout. Common variable immunodeficiency].
Revue du Praticien
Rev Prat; 2007 Oct; 57(15):1702. PubMed ID: 18080430
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.
Berger M; Rojavin M; Kiessling P; Zenker O
Clin Immunol; 2011 May; 139(2):133-41. PubMed ID: 21353644
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma.
Ihn H; Mimura Y; Yazawa N; Jinnin M; Asano Y; Yamane K; Tamaki K
Br J Dermatol; 2007 May; 156(5):1058-60. PubMed ID: 17381465
[No Abstract] [Full Text] [Related]
10. Giving intravenous immunoglobulin.
Scherf R; White-Reid K
RN; 2008 Jan; 71(1):29-34; quiz 35. PubMed ID: 18271361
[No Abstract] [Full Text] [Related]
11. Successful treatment of systemic lupus erythematosus with subcutaneous immunoglobulin.
Brasileiro A; Fonseca Oliveira J; Pinheiro S; Paiva-Lopes MJ
Lupus; 2016 May; 25(6):663-5. PubMed ID: 26846694
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies.
Dams ET; van der Meer JW
Lancet; 1995 Apr; 345(8953):864. PubMed ID: 7898254
[No Abstract] [Full Text] [Related]
13. Intravenous immunoglobulin therapy: the process, the product, the patient, and the pocketbook. Introduction.
Harvey RD
Pharmacotherapy; 2005 Nov; 25(11 Pt 2):71S-72S. PubMed ID: 16229676
[No Abstract] [Full Text] [Related]
14. [The new domestic immunoglobulin G gabriglobin in complex therapy of immunodeficiency states and infectious pathology].
Pas'ko VG; Latysheva TV; Nikiforov VV; Mostovskaia EV; Denisov AK; Kondrashin IuI
Voen Med Zh; 2006 Jul; 327(7):40-2. PubMed ID: 16977880
[No Abstract] [Full Text] [Related]
15. Europe immunoglobulin map.
Šedivá A; Chapel H; Gardulf A;
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):141-3. PubMed ID: 25546797
[No Abstract] [Full Text] [Related]
16. The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin.
Cocito D; Serra G; Falcone Y; Paolasso I
J Peripher Nerv Syst; 2011 Jun; 16(2):150-2. PubMed ID: 21692916
[No Abstract] [Full Text] [Related]
17. Update on the use of immunoglobulin in human disease: A review of evidence.
Perez EE; Orange JS; Bonilla F; Chinen J; Chinn IK; Dorsey M; El-Gamal Y; Harville TO; Hossny E; Mazer B; Nelson R; Secord E; Jordan SC; Stiehm ER; Vo AA; Ballow M
J Allergy Clin Immunol; 2017 Mar; 139(3S):S1-S46. PubMed ID: 28041678
[TBL] [Abstract][Full Text] [Related]
18. High dose intravenous immunoglobulin treatment: mechanisms of action.
Boros P; Gondolesi G; Bromberg JS
Liver Transpl; 2005 Dec; 11(12):1469-80. PubMed ID: 16315304
[TBL] [Abstract][Full Text] [Related]
19. The assessment and management of primary antibody deficiency.
Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R;
N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626
[No Abstract] [Full Text] [Related]
20. [Indications for intravenous immunoglobulins].
Spertini F
Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
